Delivery Order SPE2DB22D2211-SPE2DB25FSDMH
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $18,543.22 to AmerisourceBergen Drug Corp for the supply of Sprycel 70 mg tablets (60-count units). This competitive award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Sprycel 140 mg tablets (30-count units) under a firm fixed-price contract. The delivery order, valued at $5,570.37 with a completion date of July 29, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a competitive delivery order by the Defense Logistics Agency valued at $15,067.36 for the supply of Sprycel 100 mg tablets in quantities of 30. The contract is classified as firm fixed price and carries an ultimate completion date of August 12, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $18,016.65 delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of Sprycel 80 mg tablets (quantity 30s). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025. This delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a $5,665.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sprycel 100 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive award carries no set-aside designation and is to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, fulfills this order as a...
- The Defense Logistics Agency awarded a delivery order valued at $12,785.44 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed price, non-set-aside contract is classified as a delivery order and will be performed at the contractor's location in Conshohocken, Pennsylvania. Sprycel is a targeted cancer therapy medication, reflecting the Defense Logistics Agency's ongoing...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Sprycel 140mg tablets (30-count units) with a ceiling value of $11,140.74. This firm fixed-price delivery order, which carries an ultimate completion date of August 14, 2025, represents a non-competitive, non-set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order (SPE2DX15D3008|SPE2DX24F11LW) worth $23,962.98 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product Sprycel 50 mg Tablet 60s, with an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp, headquartered in Conshohocken, PA, is the prime contractor on this delivery order and has received multiple federal...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,142,252 units of the prescription medication Sprycel (100 mg tablet, 30-count) at a ceiling value of $11,701.09. The contract is a firm-fixed price, non-set-aside award with a period of performance through May 6, 2025. AmerisourceBergen holds a substantial Indefinite...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,013.24 contract is for the supply of 4,567,997,991 tablets of the medication Sprycel (100 mg). The contract has an ultimate completion date of April 23, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDMHDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 30 tablets of Sprycel 100 mg, a targeted cancer therapy medication, with a ceiling value of $17,467.68. The contract was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a firm fixed-price procurement. This delivery order is classified as a child contract, indicating it was issued under a larger umbrella agreement. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, reflecting open and competitive procurement practices. This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery/Indefinite Quantity (IDIQ) contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems globally. As a major pharmaceutical distributor specializing in federal medical procurement, AmerisourceBergen routinely fulfills critical medication needs for the Defense Health Agency and other federal healthcare customers through competitively awarded delivery orders under this expansive pharmaceutical supply agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.5k | 8/22/25 |